RECENTLY a procedure was reported by which it is possible to alleviate new or fresh phenomena in multiple sclerosis.1 In brief, the procedure rests upon the use of vasodilation, but the vasodilation has to be employed in certain specific ways. It cannot be used according to any fixed routine; the type of medication, the dosage, and the frequency of administration often vary with each patient and at different stages in each patient's course. Hence, the procedure is not as simple as one might wish; yet it seems to be effective.
The background and logic, as well as the essential details of the procedure, have been described earlier.1 Here it is sufficient to mention the belief that the problem of spontaneous remissions has been controlled so far as the evaluation of rapidly acting therapeutic agents is concerned; relief of the fresh phenomena occurs repeatedly and predictably within a few
BRICKNER RM. ESSENTIAL PRECAUTIONS IN THE TREATMENT OF NEW PHENOMENA IN MULTIPLE SCLEROSIS. AMA Arch NeurPsych. 1953;70(4):483–488. doi:10.1001/archneurpsyc.1953.02320340073007
Customize your JAMA Network experience by selecting one or more topics from the list below.